Ocumetics Technology Corp Stock Shares Outstanding
OTC Stock | 0.32 0.00 0.00% |
Ocumetics Technology Corp fundamentals help investors to digest information that contributes to Ocumetics Technology's financial success or failures. It also enables traders to predict the movement of Ocumetics Stock. The fundamental analysis module provides a way to measure Ocumetics Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ocumetics Technology stock.
Common Stock Shares Outstanding is likely to drop to about 123.9 M in 2025. Ocumetics | Shares Outstanding |
Ocumetics Technology Corp Company Shares Outstanding Analysis
Ocumetics Technology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Ocumetics Technology Shares Outstanding | 119.77 M |
Most of Ocumetics Technology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ocumetics Technology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ocumetics Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Ocumetics Technology is extremely important. It helps to project a fair market value of Ocumetics Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Ocumetics Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ocumetics Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ocumetics Technology's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Ocumetics Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Ocumetics Technology Corp has 119.77 M of shares currently outstending. This is 33.66% lower than that of the Health Care Equipment & Supplies sector and 39.43% higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 79.05% higher than that of the company.
Ocumetics Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ocumetics Technology's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ocumetics Technology could also be used in its relative valuation, which is a method of valuing Ocumetics Technology by comparing valuation metrics of similar companies.Ocumetics Technology is currently under evaluation in shares outstanding category among its peers.
Ocumetics Fundamentals
Return On Equity | -11.23 | ||||
Return On Asset | -0.79 | ||||
Current Valuation | 40.01 M | ||||
Shares Outstanding | 119.77 M | ||||
Shares Owned By Insiders | 46.05 % | ||||
Number Of Shares Shorted | 10.96 K | ||||
Price To Book | 400.96 X | ||||
EBITDA | (2.59 M) | ||||
Net Income | (3.64 M) | ||||
Total Debt | 945.33 K | ||||
Book Value Per Share | 0.02 X | ||||
Cash Flow From Operations | (2.05 M) | ||||
Short Ratio | 1.45 X | ||||
Earnings Per Share | (0.02) X | ||||
Beta | -1.12 | ||||
Market Capitalization | 37.73 M | ||||
Total Asset | 1.04 M | ||||
Retained Earnings | (9.18 M) | ||||
Working Capital | (312.69 K) | ||||
Net Asset | 1.04 M |
About Ocumetics Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ocumetics Technology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocumetics Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocumetics Technology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ocumetics Stock Analysis
When running Ocumetics Technology's price analysis, check to measure Ocumetics Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocumetics Technology is operating at the current time. Most of Ocumetics Technology's value examination focuses on studying past and present price action to predict the probability of Ocumetics Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocumetics Technology's price. Additionally, you may evaluate how the addition of Ocumetics Technology to your portfolios can decrease your overall portfolio volatility.